Jin Bo
Dec 9, 2010

Drug ads might not translate to sales as expected : Synovate

HONG KONG – Drugs ads are effective in raising people’s awareness of their own health, but not so effective in persuading people to buy drugs, according to a research study on the advertising effectiveness of drug and disease-related ads launched by Synovate today.

Drug ads might not translate to sales as expected : Synovate

Only one in three respondents (36 per cent) said these ads have raised their health consciousness, while only nearly 15 per cent said they have purchased or taken the drugs because of the ads.

"This does not mean drug ads are ineffective," said Carmen Li, research director of Synovate Healthcare in Hong Kong.

"By educating consumers that such medicines and newly-improved drugs are available, it is the first step to empower consumers to and find out more from their doctors, to establish a dialogue on their own health, versus the traditional one-way flow of information," she added.

A total of 38 per cent of respondents indicated they found drug and disease-related ads trustworthy.

The top drugs and disease-related advertisement most Hong Kong respondents recall are related to cancer, recognised by one in four people. Over 70 per cent indicated they have seen a drug or disease-related ad on television, the top medium, followed by one in four from newspapers.

Source:
Campaign China

Related Articles

Just Published

16 hours ago

Lululemon hands media account to GroupM in key ...

The business was won from Havas after a competitive pitch.

17 hours ago

Agency Report Cards 2024: We grade 25 APAC networks

The grades are in for Campaign Asia's 22nd annual evaluation of APAC agency networks. Subscribe to read our detailed analyses.

17 hours ago

GroupM restructures across Asia, Indonesia ...

Staffing cuts across Asia have begun as GroupM transitions to a “single operating model” under the soon-to-be-rebranded WPP Media banner.

18 hours ago

Agency Report Card 2024: DDB

A storied legacy weighed down by churn, uneven creative output, and account losses. As organisational change looms, DDB must reignite its creative firepower or risk fading behind siblings TBWA and BBDO.